Prostate cancer screening

Medical Clinics of North America

Volumn 80, Issue 1, 1996, Pages 83-98

  Hostetler, R M ^a   Mandel, I G ^a   Marshburn, J ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; CANCER SCREENING; CLINICAL PROTOCOL; CLINICAL TRIAL; EARLY DIAGNOSIS; HUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME;

EID: 0030028550     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70428-4     Document Type: Article

References (70)

1. Benson M. I. Whang C. Olsson The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen J Urol 147 1992 817
2. Benson M. I. Whang A. Pantuck Prostate specific antigen density: A means of distinguishing benign prostate hypertrophy and prostate cancer J Urol 147 1992 815
3. Bosland M. The etiopathogenesis of prostatic cancer with special reference to environmental factors Adv Cancer Res 51 1988 1 106
4. Brawer M. How to use prostate-specific antigen in the early detection or screening for prostatic carcinoma CA Cancer J Clin 45 1995 148
5. Brawer M. E. Aramburu G. Chen The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostate carcinoma J Urol 150 1993 369
6. Brawer M. M. Chetner J. Beatie Screening for prostatic carcinoma with prostate specific antigen J Urol 147 1992 841
7. Brawer M. M. Wener P. Daum Method to method variation in assays for PSA J Urol 151 suppl 1994 450A
8. Bretton P. W. Evans J. Borden The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma Cancer 74 1994 2991
9. Carter B.S. G. Steinberg T. Beaty Familial risk factors for prostate cancer Cancer Surv 11 1991 5
10. Carter H.B. J. Pearson E. Metter Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease JAMA 267 1992 2215
11. Catalona W.J. J. Richie F. Ahmana Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a Multicenter clinical trial of 6,630 men J Urol 151 1994 1283
12. Catalona W.J. D. Smith T. Ratliff Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening JAMA 270 1993 984
13. Chancellor M. C. VanAppledorn Value of transrectal prostate ultrasonography pretransurethral prostatectomy in screening for occult prostate carcinoma Urology 41 1993 590
14. Chodak D.W. R. Thisted G. Gerber Results of conservative management of clinically localized prostate cancer N Engl J Med 330 1994 242
15. Cooner W. B. Mosley C. Rutherford Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate-specific antigen J Urol 143 1990 1146
16. Crawford E.D. Report on the 1992 Prostate Cancer Awareness Week [abstr] J Urol 149 1993 55A
17. Dorr V. S. Williamson R. Stephens An evaluation of prostate-specific antigen as a screening test for prostate cancer Arch Intern Med 153 1993 2529
18. Frame P. Health maintenance in clinical practice: Strategies and barriers Am Fam Physician 45 1992 1192
19. Gann P. C. Hennekens F. Sacks A prospective study of plasma fatty acids and risk of prostate cancer J Natl Cancer Inst 86 1994 281
20. Gann P.H. C. Hennekens M. Stampfer A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer JAMA 273 1995 289
21. Gibbons R.P. Localized prostate carcinoma Cancer 72 1993 2865
22. Giovannucci E. Epidemiologic characteristics of prostate cancer Cancer 75 1995 1766
23. Giovannucci E. A. Ascherio E. Rimm A prospective cohort study of vasectomy and prostate cancer in US men JAMA 269 1993 873
24. Giovannucci E. T. Tosteson F. Speizer A retrospective cohort study of vasectomy and prostate cancer in US men JAMA 169 1993 878
25. Graverson P.H. D.K. Corle K.T. Nielsen Radical prostatectomy versus expectant primary treatment in stages I or II prostate cancer: A 15-years follow-up Urology 128 1990 502
26. Hahn D. R. Roberts PSA screening for asymptomatic prostate cancer: Truth in advertising J Fam Pract 37 1993 432
27. Haid M. D. Rabin K. King Digital rectal examination, serum prostate specific antigen, and prostatic ultrasound: How effective is this diagnostic triad? J Surg Oncol 56 1994 32
28. Hicks R.J. R. Hamm D. Bemben Prostate cancer screening, what family physicians believe is best Arch Fam Med 4 1995 317
29. Johnson J.-E. R. Bergstrom H.O. Adami High 10-year survival rate in patients with early untreated prostate cancer JAMA 267 1993 2191
30. Komatsu K. N. Wehner A. Prestigiacomo Variation of serum prostate specific antigen in 814 men from a screening population: Intra-individual assay variation is greater than the repeat assay variation J Urol 151 suppl 1994 401A
31. Krahn M. J. Mahoney M. Eckman Screening of prostate cancer: A decision analytic view JAMA 272 1994 773
32. Letters to Editor: Screening for prostate cancer JAMA 273 1995 1173
33. Letters to Editor: Preventive health services N Engl J Med 331 1994 1136
34. Letters to Editor: Prostate cancer screening Ann Intern Med 120 1994 1052
35. Lilja H. T. Bjork P. Abrahamsson Improved separation between normals, BPH and carcinoma of the prostate by measuring free, complexed and total concentrations of prostate specific antigen J Urol 151 suppl 1994 400A
36. Littrup P.J. R. Kane C. Mettlin Cost-effective prostate cancer detection: Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project Cancer 74 1994 3146
37. Litwin M.S. B. Leake R.D. Hays Quality-of-life outcomes in men treated for localized prostate cancer JAMA 273 1995 129
38. Lu-Yao G. E. Greenberg Changes in prostate cancer incidence and treatment in USA Lancet 343 1994 251
39. Mettlin C. G. Jones H. Averette Defining and updating the ACS guidelines for the cancer related check up, prostate and endometrial cancer CA Cancer J Clin 43 1993 42
40. Mettlin C. P. Littrup R. Kane Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National prostate Cancer Detection Project Cancer 74 1994 1615
41. Mettlin C. N. Natarajan R. Huben Vasectomy and prostate cancer risk Am J Epidemiol 132 1990 1056
42. Miller B. Ries L. Hankey B. SEER Cancer Statistics Review: 1973-1990. Publication No. 93-2789 1993 National Cancer Institute, National Institutes of Health Bethesda, MD
43. Monseur J. F. Malherbe Calculation of prostatic volume by endorectal ultrasonography J Urol (French) 92 1992 78
44. Murphy G. N. Natarajan J. Pontes The national survey of prostate cancer in the United States by the American College of Surgeons J Urol 127 1982 928
45. Nishiya M. G. Miller D. Lookner Prostate specific antigen density in patients with histologically proven prostate carcinoma Cancer 74 1994 3002
46. Oesterling J.E. W. Cooner S. Jacobsen Influence of patient age on the serum PSA concentration-an important clinical observation Urol Clin North Am 20 1993 671
47. Oesterling J.E. S. Jacobsen G. Christopher Serum prostate-specific antigen in a community-based population of healthy men-establishment of age-specific reference ranges JAMA 270 1993 860
48. Olson M. H. Posniak S. Fisher Directed and random biopsies of the prostate: Indications based on combined results of transrectal sonography and prostate-specific antigen density determinations AJR Am J Roentgenol 163 1994 1407
49. Pearson J.D. H.B. Carter Natural history of changes in prostate specific antigen in early stage prostate cancer J Urol 152 1994 1743
50. Pearson J.D. C. Morrell P. Landis Mixed-effects regression models for studying the natural history of prostate disease Stat Med 13 1994 587
51. Petros J. W. Catalona Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer J Urol 147 1992 1574
52. Petteway J. M. Brawer Age specific vs. 4.0 ng/ml as a PSA cutoff in the screening population: Impact on cancer detection J Urol 153 suppl 1995 465A
53. Pollack H. M. Resnick Prostate-specific antigen and screening for prostate cancer: Much ado about something? Radiology 189 1993 353
54. Porter A. J. Blasko P. Grimm Brachytherapy for prostate cancer Ca Cancer J Clin 45 1995 165
55. Porter J.R. R. Hayward M. Brawer The significance of short-term PSA change in men undergoing ultrasound-guided prostate biopsy J Urol 151 suppl 1994 293A
56. Rahmouni A. A. Yang C. Tempany Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography J Comput Assist Tomogr 16 1992 935
57. Scardino P. R. Weaver M. Hudson Early detection of prostate cancer Hum Pathol 23 1992 211
58. Shapiro A. P. Lebensart D. Pode The clinical utility of transrectal ultrasound and digital rectal examination in the diagnosis of prostate cancer Br J Radiol 67 1994 668
59. Slawin K. M. Ohoro O. Dillioglugil Screening for prostate cancer: An analysis of the early experience CA Cancer J Clin 45 1995 134
60. Snowden D. R. Phillips W. Choi Diet, obesity and risk of fatal prostate cancer Am J Epidemiol 120 1984 244
61. Sporn M. A. Roberts Role of retinoids in differentiation and carcinogenesis J Natl Cancer Inst 73 1984 1381
62. Stamey T. Z. Chen A. Prestigiacomo Serum prostate specific antigen binding α antichymotrypsin: Influence of cancer volume, location and therapeutic selection of resistant clones J Urol 152 1994 1510
63. Steinberg G. B. Carter T. Beaty Family history and the risk of prostate cancer Prostate 17 1990 337
64. Steinmetz K. J. Potter A review of vegetables, fruit, and cancer: I. Epidemiology Cancer Causes Control 2 1991 427
65. Terris M.K. T. Stamey Determination of prostate volume by transrectal ultrasound J Urol 145 1991 984
66. Walsh P.C. A decision analysis of alternative treatment strategies for clinically localized prostate cancer J Urol 150 1993 1330
67. Weber J.P. J. Oesterling C. Peters The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostate hyperplasia J Urol 141 1989 987
68. Williams R.B. M. Boles R. Johnson Use of prostate-specific antigen for prostate cancer screening in primary care practice Arch Fam Med 4 1995 311
69. Wilt T.J. M.K. Brawer The prostate cancer intervention versus observation trial: A randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer Urology 152 1994 1910
70. Wingo P. T. Tong S. Bolden Cancer statistics, 1985 CA Cancer J Clin 14 1985 8